Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-04 Sale |
2025-03-04 4:21 pm |
Intellia Therapeutics Inc. | NTLA | BASTA JAMES EVP, General Counsel |
2,572 | $8.99 | $23,122 | 169,068 (Direct) |
View |
| 2025-01-03 Sale |
2025-01-07 5:22 pm |
Intellia Therapeutics Inc. | NTLA | BASTA JAMES EVP, General Counsel |
7,074 | $12.18 | $86,161 | 74,497 (Direct) |
View |
| 2024-03-04 Sale |
2024-03-05 4:10 pm |
Intellia Therapeutics Inc. | NTLA | BASTA JAMES EVP, General Counsel |
2,297 | $32.99 | $75,778 | 128,323 (Direct) |
View |
| 2024-01-03 Sale |
2024-01-05 4:45 pm |
Intellia Therapeutics Inc. | NTLA | BASTA JAMES EVP, General Counsel |
3,805 | $29.46 | $112,095 | 51,474 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 5:10 pm |
Intellia Therapeutics Inc. | NTLA | BASTA JAMES EVP, General Counsel |
1,088 | $43.88 | $47,741 | 89,953 (Direct) |
View |
| 2023-01-04 Sale |
2023-01-06 5:19 pm |
Intellia Therapeutics Inc. | NTLA | BASTA JAMES EVP, General Counsel |
1,138 | $37.21 | $42,345 | 19,559 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-01 Option Award |
2025-03-04 4:21 pm |
N/A 2035-02-28 |
Intellia Therapeutics Inc. | NTLA | BASTA JAMES EVP, General Counsel |
97,143 | $0 | 169,068 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 4:10 pm |
N/A 2034-02-28 |
Intellia Therapeutics Inc. | NTLA | BASTA JAMES EVP, General Counsel |
79,146 | $0 | 128,323 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 5:10 pm |
N/A 2033-02-28 |
Intellia Therapeutics Inc. | NTLA | BASTA JAMES EVP, General Counsel |
71,482 | $0 | 89,953 (Direct) |
View |
| 2022-03-01 Option Award(A) |
2022-03-04 9:09 pm |
N/A 2032-02-28 |
Intellia Therapeutics Inc. | NTLA | BASTA JAMES EVP, General Counsel |
14,109 | $0 | 14,109 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 7:34 pm |
N/A 2032-02-28 |
Intellia Therapeutics Inc. | NTLA | BASTA JAMES EVP, General Counsel |
20,697 | $0 | 30,345 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-06 4:44 pm |
N/A 2031-06-30 |
Intellia Therapeutics Inc. | NTLA | BASTA JAMES EVP, General Counsel |
130,000 | $0 | 130,000 (Direct) |
View |
| 2021-01-26 Option Award |
2021-01-28 5:31 pm |
N/A 2031-01-25 |
Kura Oncology Inc. | KURA | BASTA JAMES Chief Legal Officer |
125,000 | $0 | 125,000 (Direct) |
View |